CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response

DOI: 10.1080/2162402X.2018.1502904

Keywords: CD27, tumor immunotherapy, peptide vaccine, adjuvant, monoclonal antibody

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text